tiprankstipranks
TipRanksTop Financial ExpertsInsidersInvus Public Equities, Lp

Invus Public Equities, Lp Insider Profile

4 Followers
Invus Public Equities, Lp, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 11.26M shares in Scholar Rock Holding (Ticker: SRRK), holds 8.59M shares in GlycoMimetics (Ticker: GLYC), holds 2.27M shares in Omega Therapeutics (Ticker: OMGA). Most recently, Invus Public Equities, Lp Bought ― shares of Scholar Rock Holding on Oct 16, 2023 for an estimated value of 15.09M.
tipranks
Invus Public Equities, Lp

Invus Public Equities, Lp
Lexicon Pharmaceuticals (LXRX)
Director, Ten Percent Owner

Ranked #89,876 out of 105,137 Corporate Insiders

Profitable Transactions

32%
8 out of 25 Profitable Transactions

Average Return

-11.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$212M
41.60%
39.92%
5.75%
4.77%
7.97% Others
A breakdown of Invus Public Equities, Lp's holdings

Insider Roles

Scholar Rock Holding
(SRRK)
Ten Percent Owner
Lexicon Pharmaceuticals
(LXRX)
Director, Ten Percent Owner
GlycoMimetics
(GLYC)
Ten Percent Owner
Seer
(SEER)
Ten Percent Owner
+4 other positions
Roles that Invus Public Equities, Lp holds in companies

Most Profitable Insider Trade

Stock:
Furiex Pharmaceuticals
(FURX)
Rating:Informative Buy
Date:Feb 19, 2013 - Feb 19, 2014
Return:+169.30%
The most profitable trade made by Invus Public Equities, Lp

Invus Public Equities, Lp's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lexicon Pharmaceuticals
Dec 17, 2020
Director, Ten Percent Owner
Informative Buy
35.00M
$84.70M
Generation Bio
Jun 18, 2020
Ten Percent Owner
Uninformative Buy
$9.12M
SQZ Biotechnologies
Nov 03, 2020
Ten Percent Owner
Uninformative Buy
$96.38K
Seer
Feb 03, 2021
Ten Percent Owner
Informative Sell
16.20M
$10.11M
Omega Therapeutics
Aug 03, 2021
Ten Percent Owner
Uninformative Buy
$3.98M
Scholar Rock Holding
Oct 16, 2023
Ten Percent Owner
Informative Buy
15.09M
$88.27M
GlycoMimetics
Feb 28, 2023
Ten Percent Owner
Informative Buy
170.00K
$12.20M
Agenus
Ten Percent Owner
$3.71M
FURX
Furiex Pharmaceuticals
Feb 19, 2013
Informative Buy
List of latest transactions for each holding click on a transaction to see Invus Public Equities, Lp's performance on stock

Invus Public Equities, Lp insider profile FAQ

What is the percentage of profitable transactions made by Invus Public Equities, Lp?
The percentage of profitable transactions made by Invus Public Equities, Lp is 32%.
    What is the average return per transaction made by Invus Public Equities, Lp?
    The average return per transaction made by Invus Public Equities, Lp is -11.20%.
      What stocks does Invus Public Equities, Lp hold?
      Invus Public Equities, Lp holds: LXRX, GBIO, SQZB, SEER, OMGA, SRRK, GLYC, AGEN, FURX stocks.
        What was Invus Public Equities, Lp’s latest transaction?
        Invus Public Equities, Lp latest transaction was an Informative Buy of $15.09M.
          What was Invus Public Equities, Lp's most profitable transaction?
          Invus Public Equities, Lp’s most profitable transaction was an Informative Buy of FURX stock on February 19, 2013. The return on the trade was 169.30%.
            What is Invus Public Equities, Lp's role in Lexicon Pharmaceuticals?
            Invus Public Equities, Lp's role in Lexicon Pharmaceuticals is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.